Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Oligodendroglioma history and symptoms

Introduction

Overview

Overview

When evaluating a patient for oligodendroglioma, a detailed history of the presenting symptom (onset, duration, and progression), other associated symptoms, a thorough past medical history review, and review of common risk factors such as family history of brain tumors. Oligodendroglioma is a slow–growing, infiltrative tumor that may be clinically silent for many years. With tumor progression, symptoms may vary depending upon the location, size, and rate of tumor growth. Oligodendroglioma mainly involves the frontal lobe. Symptoms associated with oligodendroglioma include seizure, headache, nausea, vomiting, vertigo, visual loss, diplopia, strabismus, muscle weakness, numbness, speech difficulties, mood disturbances, personality changes, memory problems, low energy, fatigue, urge to sleep, loss of interest in daily activities, abulia, lack of spontaneity, loss of consciousness with syncope (few tonic-clonic jerks), and classic triad of headache, nausea, and papilledema due to raised intracranial pressure.

History

History

Symptoms

Symptoms

Oligodendrogliomas symptoms according to tumor site
Tumor site of involvement Clinical features
Frontal lobe
Temporal lobe
References

References

  1. ↑ McCarthy BJ, Rankin KM, Aldape K, Bondy ML, BrΓ€nnstrΓΆm T, Broholm H; et al. (2011). “Risk factors for oligodendroglial tumors: a pooled international study”. Neuro Oncol. 13 (2): 242–50. doi:10.1093/neuonc/noq173. PMCΒ 3064625. PMIDΒ 21149253.
  2. ↑ Douay X, Daems-Monpeurt C, Labalette P, Blond S, Petit H (1997). “[Bilateral 3rd cranial nerve palsy disclosing oligodendroglioma]”. Rev Neurol (Paris). 153 (6–7): 430–2. PMIDΒ 9684012.
  3. ↑ Hata N, Shono T, Mizoguchi M, Matsumoto K, Guan Y, Nagata S; et al. (2007). “Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy”. Neurol Res. 29 (7): 723–6. doi:10.1179/016164107X208068. PMIDΒ 17553214.
  4. ↑ Ogasawara H, Kiya K, Uozumi T, Sugiyama K, Kawamoto K, Ohta M (1990). “Multiple oligodendroglioma–case report”. Neurol Med Chir (Tokyo). 30 (2): 127–31. PMIDΒ 1695334.
  5. ↑ Raciti-Daurio C, Caruso J (1990). “Oligodendroglioma–a case presentation”. Optom Vis Sci. 67 (1): 56–8. PMIDΒ 2308753.
  6. ↑ Rodriguez FJ, Tihan T, Lin D, McDonald W, Nigro J, Feuerstein B; et al. (2014). “Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients”. Am J Surg Pathol. 38 (8): 1058–70. doi:10.1097/PAS.0000000000000221. PMCΒ 4322928. PMIDΒ 24805856.
  7. ↑ Cavaliere R, Farace E, Schiff D (2006). “Clinical implications of status epilepticus in patients with neoplasms”. Arch Neurol. 63 (12): 1746–9. doi:10.1001/archneur.63.12.1746. PMIDΒ 17172614.


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]